Intel (INTC) PT Raised to $58 at Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St futures mixed ahead of CPI, bank earnings; US-Iran tensions in focus
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Intel (INTC) PT Lowered to $55 at Deutsche Bank
October 26, 2018 9:00 AM EDTDeutsche Bank analyst Ross Seymore lowered the price target on Intel (NASDAQ: INTC) to $55.00 (from $64.00) while maintaining a Buy rating.
... MoreInvestors Are Overestimating Intel's (INTC) Competition, PT To $54 At Morgan Stanley
October 26, 2018 6:50 AM EDTMorgan Stanley analyst, Joseph Moore, reiterated his Equalweight rating on shares of Intel (NASDAQ: INTC) and raised his price target to $54 from $50 after the company reported much stronger than expected results with all core computing segments delivering upside.
The analyst... More
Active options: INTC NVDA GE AMZN MU NFLX F
October 26, 2018 5:25 AM EDTActive options: INTC NVDA GE AMZN MU NFLX F
... MoreIntel (INTC) PT Raised to $40 at Barclays
October 26, 2018 3:58 AM EDTBarclays analyst Blayne Curtis raised the price target on Intel (NASDAQ: INTC) to $40.00 (from $38.00) while maintaining a Underweight rating.
... MoreAfter-Hours Stock Movers 10/25: (MAT) (EXPE) (CMG) Higher; (SGYP) (AMZN) (GOOGL) Lower (more...)
October 25, 2018 5:53 PM EDTToday's After-Hours Movers
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) 73.6% LOWER; provided a business update. In April 2015, prior to the FDA approval and launch of TRULANCE® (plecanatide) in 2017, Synergy hired a top tier advisory firm to engage external parties and evaluate all strategic options available to the Company, including US and ex-US partnerships and a possible sale of the Company. Ultimately, there were no offers to acquire the Company and no partnership opportunities emerged in this evaluation that it believed aligned with the Company strategically or financially. As a result,... More
Tech stocks battered after disappointing Amazon and Alphabet results
October 25, 2018 4:58 PM EDTBy Noel Randewich
SAN FRANCISCO (Reuters) - So-called FANG stocks and other tech shares sank in extended trade on Thursday following disappointing quarterly reports from Amazon.com Inc (NASDAQ: AMZN) and Alphabet Inc (NASDAQ: GOOGL).
The weak results from Amazon and Google parent Alphabet were the latest setback for the high-growth quartet of stocks known as FANG, which also includes Facebook Inc (NASDAQ: FB) and Netflix Inc (NASDAQ: NFLX).
Nasdaq futures... More
Intel (INTC) Tops Q3 EPS by 25c
October 25, 2018 4:02 PM EDTIntel (NASDAQ: INTC) reported Q3 EPS of $1.40, $0.25 better than the analyst estimate of $1.15. Revenue for the quarter came in at $19.2 billion versus the consensus estimate of $18.11 billion.
For earnings history and earnings-related data on Intel (INTC) click here.
... More